AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BioGaia

Board/Management Information Sep 17, 2009

3013_rns_2009-09-17_1e0bac15-2492-44c3-9b41-1c58b7c0a086.pdf

Board/Management Information

Open in Viewer

Opens in native device viewer

Press Release 17 September 2009

Personnel changes at BioGaia

Jan Annwall Vice Managing Director, founder, Chief Financial Officer and Board member of BioGaia AB will leave his position in the company in connection with his 60th birthday in April 2010. In order to continue to utilise Jan´s experience after this date, Jan will be retained as a consultant and will be available for the company for a further period.

Jan has declared that he will continue to be available for the role of Board member at the Annual General Meeting 2010.

BioGaia´s present Controller Margareta Hagman will be appointed as both Chief Financial Officer and Controller from April 1st 2010.

Latest press releases from BioGaia:

2009-08-18 BioGaia AB Interim report 1 January – 30 June 2009 2009-06-30 BioGaia signs new agreement with Semper for unique probiotic Oral Rehydration Solution (ORS) 2009-06-11 BioGaia signs distribution agreement in Germany

For additional information contact:

Peter Rothschild, Managing Director, telephone: +46 8 -555 293 00 Jan Annwall, Deputy Managing Director, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.